DekaBank Deutsche Girozentrale’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Hold |
57,500
| – | – | ﹤0.01% | 750 |
|
|
2025
Q1 | $2.45M | Hold |
57,500
| – | – | ﹤0.01% | 695 |
|
|
2024
Q4 | $2.67M | Hold |
57,500
| – | – | ﹤0.01% | 696 |
|
|
2024
Q3 | $2.98M | Hold |
57,500
| – | – | 0.01% | 682 |
|
|
2024
Q2 | $3.07M | Hold |
57,500
| – | – | 0.01% | 677 |
|
|
2024
Q1 | $4.13M | Sell |
57,500
-17,500
| -23% | -$1.26M | 0.01% | 618 |
|
|
2023
Q4 | $6.13M | Buy |
75,000
+20,000
| +36% | +$1.63M | 0.01% | 541 |
|
|
2023
Q3 | $1.69M | Hold |
55,000
| – | – | ﹤0.01% | 778 |
|
|
2023
Q2 | $1.79M | Buy |
55,000
+11,000
| +25% | +$358K | ﹤0.01% | 773 |
|
|
2023
Q1 | $1.37M | Sell |
44,000
-12,100
| -22% | -$376K | ﹤0.01% | 803 |
|
|
2022
Q4 | $2.52M | Hold |
56,100
| – | – | 0.01% | 673 |
|
|
2022
Q3 | $2.72M | Hold |
56,100
| – | – | 0.01% | 643 |
|
|
2022
Q2 | $2.35M | Hold |
56,100
| – | – | 0.01% | 686 |
|
|
2022
Q1 | $2.05M | Buy |
56,100
+5,100
| +10% | +$186K | 0.01% | 746 |
|
|
2021
Q4 | $2.35M | Buy |
51,000
+1,400
| +3% | +$64.5K | 0.01% | 732 |
|
|
2021
Q3 | $1.66M | Buy |
49,600
+25,000
| +102% | +$834K | ﹤0.01% | 766 |
|
|
2021
Q2 | $513K | Hold |
24,600
| – | – | ﹤0.01% | 1064 |
|
|
2021
Q1 | $544K | Hold |
24,600
| – | – | ﹤0.01% | 1013 |
|
|
2020
Q4 | $505K | Sell |
24,600
-56,200
| -70% | -$1.15M | ﹤0.01% | 1017 |
|
|
2020
Q3 | $1.77M | Buy |
+80,800
| New | +$1.77M | 0.01% | 617 |
|